ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)
Top Cited Papers
- 1 June 2020
- journal article
- research article
- Published by Elsevier BV in Annals of Oncology
- Vol. 31 (6), 674-696
- https://doi.org/10.1016/j.annonc.2020.03.284
Abstract
No abstract availableFunding Information
- European Society for Medical Oncology
This publication has 203 references indexed in Scilit:
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trialThe Lancet, 2013
- The landscape of cancer genes and mutational processes in breast cancerNature, 2012
- Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trialsThe Lancet, 2012
- Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE studyHuman Mutation, 2011
- Effect of the Gonadotropin-Releasing Hormone Analogue Triptorelin on the Occurrence of Chemotherapy-Induced Early Menopause in Premenopausal Women With Breast CancerJAMA, 2011
- Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancerBreast Cancer Research and Treatment, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Analysis of local and regional recurrences in breast cancer after conservative surgeryAnnals of Oncology, 2010
- Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancerBritish Journal of Cancer, 2007
- Recent increase of breast cancer incidence among women under the age of fortyBritish Journal of Cancer, 2007